BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 820521)

  • 1. The bioavailability of enteric-coated acetylsalicylic acid: a comparison with buffered ASA in rheumatoid arthritis II.
    Canada AT; Little AH; Creighton EL
    Curr Ther Res Clin Exp; 1976 May; 19(5):554-7. PubMed ID: 820521
    [No Abstract]   [Full Text] [Related]  

  • 2. The bioavailability of enteric-coated acetylsalicylic acid: a comparative study in reheumatoid arthritis, I.
    Canada AT; Little AH
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):727-32. PubMed ID: 812651
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
    Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability.
    Portek I; Graham G; Fleming A
    Med J Aust; 1981 Jul; 2(1):39-40. PubMed ID: 6974303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double blind comparison of piroxicam and enteric coated ASA in rheumatoid arthritis. A Cooperative Multicenter Canadian trial.
    J Rheumatol; 1985 Feb; 12(1):68-77. PubMed ID: 3884806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations.
    Armstrong BK; Ukich AW; Goatcher PM
    Med J Aust; 1970 Jul; 2(4):181-3. PubMed ID: 4917130
    [No Abstract]   [Full Text] [Related]  

  • 7. [Enteric aspirin tablets and the salicylate concentration in the plasma in the morning].
    Laine V; Strandman D; Tikkanen R
    Lakartidningen; 1968 Sep; 65(39):3832-7 passim. PubMed ID: 5741894
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioavailability studies on a buffered acetylsalicylic acid preparation.
    Ekenved G; Elofsson R; Sölvell L
    Acta Pharm Suec; 1975; 12(4):323-32. PubMed ID: 1106118
    [No Abstract]   [Full Text] [Related]  

  • 9. Salicylates in the management of rheumatoid arthritis.
    Pinals RS
    Mod Treat; 1971 Nov; 8(4):796-806. PubMed ID: 5316723
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of cimetidine on bioavailability of enteric-coated aspirin tablets.
    Paton TW; Walker SE; Leung FY; Little AH
    Clin Pharm; 1983; 2(2):165-6. PubMed ID: 6883946
    [No Abstract]   [Full Text] [Related]  

  • 11. Acetylsalicylic acid metabolites in blood and urine after plain and enteric-coated tablets.
    Montgomery PR; Sitar DS
    Biopharm Drug Dispos; 1986; 7(1):21-5. PubMed ID: 3955197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of formulation of enteric coated tablets on the bioavailability of the drug. 4th Part: Influence of the enteric polymer dissolution pH on the "in vivo" absorption of aspirin from coated tablets (author's transl)].
    Delporte JP; Jaminet F
    J Pharm Belg; 1976; 31(3):263-76. PubMed ID: 8603
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of omeprazole with enteric-coated salicylate tablets.
    Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood salicylate levels and clinical trials with a new form of enteric-coated aspirin: studies in rheumatoid arthritis and degenerative joint disease.
    Baum J
    J Clin Pharmacol J New Drugs; 1970; 10(2):132-7. PubMed ID: 4906542
    [No Abstract]   [Full Text] [Related]  

  • 15. [Salicylate dosage for children with juvenile chronic arthritis].
    Mäkelä AL; Yrjänä T
    Duodecim; 1978; 94(12):771-9. PubMed ID: 357138
    [No Abstract]   [Full Text] [Related]  

  • 16. Enteric coated aspirin today.
    Baum J
    J Rheumatol; 1985 Oct; 12(5):829-32. PubMed ID: 4087264
    [No Abstract]   [Full Text] [Related]  

  • 17. The absorption of Safapryn in patients with arthritis.
    Haslock I; Omar AS; Wright V
    Br J Clin Pract; 1976 Apr; 30(4):89-91. PubMed ID: 1268023
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimentations with a buffered compound of acetylcsalycilic acid in rheumatoid arthritis].
    Liso V; Troccoli G
    Reumatismo; 1968; 20(4):273-8. PubMed ID: 5738055
    [No Abstract]   [Full Text] [Related]  

  • 19. The dosage effect of enteric-coated ASA on serum salicylate levels.
    Woodbury JF; Ahmad S
    N S Med Bull; 1973 Jun; 52(3):123-6. PubMed ID: 4584430
    [No Abstract]   [Full Text] [Related]  

  • 20. Enteric-coated aspirin in rheumatoid arthritis.
    Bird HA; Rhind V; Leatham P; Saunders A; Wright V
    Rheumatol Rehabil; 1981 May; 20(2):116-21. PubMed ID: 6792691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.